1. bookVolume 6 (2022): Edizione 1 (January 2022)
Dettagli della rivista
License
Formato
Rivista
eISSN
2564-615X
Prima pubblicazione
30 Jan 2017
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
access type Accesso libero

Successful Mestrual Regularity and Spontaneous Pregnancies with a Resveratrol-Based Multivitamin Supplement in Women with Idiopathic Premature Ovarian Insufficiency

Pubblicato online: 24 Jan 2022
Volume & Edizione: Volume 6 (2022) - Edizione 1 (January 2022)
Pagine: 40 - 43
Dettagli della rivista
License
Formato
Rivista
eISSN
2564-615X
Prima pubblicazione
30 Jan 2017
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Abstract

Premature ovarian insufficiency (POI) is a clinical syndrome defined by loss of ovarian activity before the age of 40 years and is characterized by menstrual disturbance, follicle stimulating hormone (FSH) concentration above 40 IU/l and infertility. In some patients the best option is to conceive spontaneously since many treatment strategies remain unsuccessful or involve eggs donation. In this case report series, we describe the effects of a resveratrol-based multivitamin supplement containing trans-resveratrol, folic acid, vitamin B6, B12 and D, in six women with poor prognosis of pregnancy due to POI and evaluate the achievement of desired conception.

These women, aged less then 40 years, suffered from menstrual irregularities, anovulation and infertility. They all had normal karyotype, and no history of ovarian surgery, radiation exposure or chemotherapy. Blood test showed at least two values of FSH above 40 IU/l.

Four out of six patients with POI conceived after 3-6 months of a resveratrol-based multivitamin supplement, ultimately giving birth to a full-term baby. Regular menstrual cycle was restored in all patients after two to four months the start of treatment. In conclusion the treatment with a resveratrol-based supplement improved menstrual regularity and suggest a useful potential of this supplementation in some cases of POI.

Keywords

1. Committee Opinion Reaffirmed 2020. Primary Ovarian insufficiency in adolescents and young women. Search in Google Scholar

2. The ESHRE Guideline Group on POI, L. Webber, M. Davies, R. Anderson, J. Bartlett, D. Braat, B. Cartwright, R. Cifkova, S. de Muinck Keizer-Schrama, E. Hogervorst, F. Janse, L. Liao, V. Vlaisavljevic, C. Zillikens, N. Vermeulen, ESHRE Guideline: management of women with premature ovarian insufficiency,Human Reproduction, Volume 31, Issue 5, May 2016, Pages 926–93710.1093/humrep/dew027 Search in Google Scholar

3. Nelson LM (2009) Clinical practice. Primary ovarian insufficiency.N Engl J Med 360: 606-614.10.1056/NEJMcp0808697 Search in Google Scholar

4. Blumenfeld Z. What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF? Front Endocrinol (Lausanne). 2020 Apr 17;11:192. doi: 10.3389/fendo.2020.00192.10.3389/fendo.2020.00192 Search in Google Scholar

5. Ho Y, Sh Yang YC, Chin YT, Chou SY, Chen YR, Shih YJ, Whang-Peng J, Changou CA, Liu HL, Lin SJ, Tang HY, Lin HY, Davis PJ. Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin αvβ3 and IGF-1R. Food Chem Toxicol. 2018;120:346-55.10.1016/j.fct.2018.07.030 Search in Google Scholar

6. Bezerra MÉS, Gouveia BB, Barberino RS, Menezes VG, Macedo TJS, Cavalcante AYP, Monte APO, Santos JMS, Matos MHT. Resveratrol promotes in vitro activation of ovine primordial follicles by reducing DNA damage and enhancing granulosa cell proliferation via phosphatidylinositol 3-kinase pathway. Reprod Domest Anim. 2018;53:1298-305.10.1111/rda.13274 Search in Google Scholar

7. Hao J, Tuck AR, Sjödin MOD, Lindberg J, Sand A, Niklasson B, Argyraki M, Hovatta O, Damdimopoulou P. Resveratrol supports and alpha-naphthoflavone disrupts growth of human ovarian follicles in an in vitro tissue culture model. Toxicol Appl Pharmacol. 2018;338:73-82.10.1016/j.taap.2017.11.009 Search in Google Scholar

8. Ochiai A, Kuroda K, Ozaki R, Ikemoto Y, Murakami K, Muter J, Matsumoto A, Itakura A, Brosens JJ, Takeda S. Resveratrol inhibits decidualization by accelerating down-regulation of the CRABP2-RAR pathway in differentiating human endometrial stromal cells. Cell Death Dis 2019; 10:276.10.1038/s41419-019-1511-7 Search in Google Scholar

9. Mestre Citrinovitz AC, Langer L, Strowitzki T, Germeyer A. Resveratrol enhances decidualization of human endometrial stromal cells. Reproduction. 2020 Apr;159(4):453-463.10.1530/REP-19-0425 Search in Google Scholar

10. Jiang Y, Zhang Z, Cha L, Li L, Zhu D, Fang Z, He Z, Huang J, Pan Z. Resveratrol Plays a Protective Role against Premature Ovarian Failure and Prompts Female Germline Stem Cell Survival. Int J Mol Sci. 2019 Jul 23;20(14):3605.10.3390/ijms20143605 Search in Google Scholar

11. De Vos M, Devroey P, Fauser BC (2010) Primary ovarian insufficiency. Lancet 376: 911-921. 17.10.1016/S0140-6736(10)60355-8 Search in Google Scholar

12. Nelson LM, Covington SN, Rebar RW (2005) An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 83: 1327-1332.10.1016/j.fertnstert.2004.11.05915866564 Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo